Al Hammadi’s net profit jumps 11% in nine-months 2015
19/10/2015
Argaam Exclusive
AI Summary
Content Summary: 
Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original
sources for complete details and to verify the accuracy of the information.
View other reports
Al Hammadi Co. for Development and Investment reported a net profit of SAR 105.6 million for the first nine months of 2015, an 11 percent jump year-on-on-year (YOY) due to higher revenue, expanding its services to patients, as well as the launch of Al-Hammadi Al-Suweidi Hospital in August.
Financials (M)
| Item | 9m 2014 | 9m 2015 | Change |
|---|---|---|---|
| Revenues | 352.53 | 403.64 | 14.5 % |
| Gross Income | 153.13 | 172.17 | 12.4 % |
| Operating Income | 96.43 | 103.17 | 7.0 % |
| Net Income | 95.24 | 105.58 | 10.9 % |
| Average Shares | 160.00 | 160.00 | - |
| Earnings Per Share before unusual items (Riyals) | 0.60 | 0.60 | 0.6 % |
| EPS (Riyal) | 0.60 | 0.66 | 10.9 % |
The Saudi-listed company, which invests in hospitals, reported a net profit of SAR 27.7 million during Q3-2015, marking a nine percent increase compared to the same quarter of the previous year. However, net profit dropped 25 percent compared to the previous quarter on seasonal impact and higher operating costs.
Compared With The
Current Quarter Comparison (M)
| Item | Q3 2014 | Q3 2015 | Change |
|---|---|---|---|
| Revenues | 108.83 | 136.80 | 25.7 % |
| Gross Income | 44.74 | 57.97 | 29.6 % |
| Operating Income | 24.77 | 31.92 | 28.8 % |
| Net Income | 25.42 | 27.69 | 8.9 % |
| Average Shares | 160.00 | 160.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.16 | 0.17 | 8.9 % |
| EPS (Riyal) | 0.16 | 0.17 | 8.9 % |
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
|---|---|---|---|---|---|---|
| Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 33.35 | (7.3 %) |
| Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 37.91 | 6.0 % |
| Q3 2015 | 136.80 | 25.7 % | 57.97 | 29.6 % | 31.92 | 28.8 % |
Profit Performance (Million)
| Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS(Riyal) |
|---|---|---|---|---|---|---|
| Q1 2015 | 41.01 | 19.8 % | 0.26 | 9.80 | 31.21 | 0.20 |
| Q2 2015 | 36.89 | 3.6 % | 0.23 | - | 36.89 | 0.23 |
| Q3 2015 | 27.69 | 8.9 % | 0.17 | - | 27.69 | 0.17 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
| Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
| Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
| Q4 2014 | 43.39 % | 30.09 % | 26.75 % |
| 2014 | 43.39 % | 30.07 % | 26.75 % |
| Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
| Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
| Q3 2015 | 42.80 % | 29.71 % | 24.29 % |
Compared With The
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Earnings Per Share before unusual items (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
| Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
| Q3 2015 | 160.00 | 0.87 | 0.81 | 8.44 |
Multiple Ratios (End of Period Price)
| Period | P/E | Recurring P/E | Price/book |
|---|---|---|---|
| Q1 2015 | 51.53 | 55.54 | 5.14 |
| Q2 2015 | 54.13 | 58.30 | 5.61 |
| Q3 2015 | 44.33 | 47.69 | 4.57 |
Business Segments (Million)
2015
| Period | Healthcare services | Pharmaceutical sales revenue - Pharmacies |
|---|
Analysts Estimates (Million)
| Item | Profit (Expected) | Profit (Actual) | Change |
|---|---|---|---|
| Average | 31.17 | 27.69 |
Estimates vs Actual (Million)
| Item | Profit (Expected) | Profit (Actual) | Change |
|---|---|---|---|
| OSOOL AND BAKHEET | 25.10 | 27.69 | |
| AlJazira Capital | 31.40 | 27.69 | |
| 99Hlala Capital | 37.00 | 27.69 |
| Current | |
| Market Cap (M Riyal) | 5,568.01 |
| Enterprise Value (EV) (M Riyal) | 5,646.93 |
| Shares Outstanding ((M)) | 160.00 |
| EPS ( Riyal) (TTM) | 1.83 |
| Book Value (BV) ( Riyal) | 12.42 |
| Par Value ( Riyal) | 10.00 |
| Recurring P/E | 19.02 |
| P/E (TTM) | 19.02 |
| Price/book | 2.80 |
| Return on Average Assets (%) (TTM) | 11.2 |
| Return on Average Equity (%) (TTM) | 15.0 |
| EV/adj EBITDA | 15.26 |
| EV/Revenues | 4.65 |
Share Price
Al Hammadi Holding (ALHAMMADI)
Follow us on
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Comments Analysis: